| 1. |  3PBIOVIAN Noáin (Navarra), Spain | CDMO | Commercial | VIEW |
| 2. |  3PBIOVIAN Turku, Finland (Biovian) / Pamplona, Spain (3P) - now pan-European | CDMO | CDMO - supports clients' pipelines from Discovery through Commercial | VIEW |
| 3. |  3S Pharma Services Bucharest, Romania | CRO | Commercial | VIEW |
| 4. |  4Care Lifescience Ahmedabad, India | CDMO | Commercial | VIEW |
| 5. |  ABX advanced biochemical compounds Radeberg, Germany | CDMO | Commercial | VIEW |
| 6. |  ADARx Pharmaceuticals San Diego, USA | Biotech | Phase 3 | VIEW |
| 7. |  AGS Therapeutics Paris, France | Biotech | Preclinical | VIEW |
| 8. |  ARENSIA Exploratory Medicine Dusseldorf, Germany | CRO | Commercial | VIEW |
| 9. |  AWINSA Life Sciences New Delhi, India | CRO | - | VIEW |
| 10. |  Acadia Pharmaceuticals Inc. San Diego, USA | Biotech | Commercial | VIEW |
| 11. |  Access Community Clinical Trials Baton Rouge, Louisiana | CRO | Commercial | VIEW |
| 12. |  Adamed Pharma Pieńków, Poland | Pharma | Commercial | VIEW |
| 13. |  Adelco S.A. Moschato, Athens, Greece | CDMO | Commercial | VIEW |
| 14. |  Adelphi Targis Barcelona, Spain | CRO | - | VIEW |
| 15. |  Adragos Pharma Munich, Germany | CDMO | Commercial | VIEW |
| 16. |  Advanced Clinical Deerfield, Illinois, USA | CRO | Commercial | VIEW |
| 17. |  Advanz Pharma London, United Kingdom | Biotech | Commercial|Phase 2|Phase 3 | VIEW |
| 18. |  Advity Research Private Limited Hyderabad, India | CRO | - | VIEW |
| 19. |  Agostino Gemelli University Hospital Rome, Italy | CRO | Phase 1-4 | VIEW |
| 20. |  Aico Worldwide Boston, USA | Digital Health | Commercial | VIEW |
| 21. |  Aixial Group Boulogne-Billancourt, France | CRO | - | VIEW |
| 22. |  Ajou University Suwon, South Korea | Biotech | Phase 3 | VIEW |
| 23. |  Akkodis Zurich, Switzerland | CRO | Commercial | VIEW |
| 24. |  Aleon Pharma International, Inc. Parsippany, New Jersey, USA | CRO | N/A | VIEW |
| 25. |  Alexion Pharmaceuticals Boston, USA | Pharma | Commercial | VIEW |
| 26. |  Alkaloid AD Skopje Skopje, North Macedonia | Pharma | Commercial | VIEW |
| 27. |  Alkem Laboratories Mumbai, India | Pharma | Commercial | VIEW |
| 28. |  Alkermes plc Dublin, Ireland | Biotech | Commercial | VIEW |
| 29. |  Allucent Cary, North Carolina, USA | CRO | Commercial | VIEW |
| 30. |  Alumis Inc. South San Francisco, USA | Biotech | Phase 3 | VIEW |
| 31. |  Ami Organics Limited Surat, India | CDMO | Commercial | VIEW |
| 32. |  Amneal Pharmaceuticals Bridgewater, New Jersey, USA | Pharma | Commercial | VIEW |
| 33. |  Angelini Pharma Rome, Italy | Biotech | Phase 3 | VIEW |
| 34. |  | Pharma | Commercial | VIEW |
| 35. |  Anyea Therapeutics Co., Ltd. Shanghai, China | Biotech | Discovery | VIEW |
| 36. |  Aparito Wrexham, United Kingdom | Digital Health | Commercial | VIEW |
| 37. |  AplusA Research Lyon, France | CRO | - | VIEW |
| 38. |  Apotex Inc. Toronto, Canada | Biotech | Commercial | VIEW |
| 39. |  Apothecon Pharmaceuticals Pvt. Ltd. Vadodara, India | CDMO | Commercial | VIEW |
| 40. |  Applied Pathology Systems Worcester, Massachusetts, USA | CRO | Commercial | VIEW |
| 41. |  Apsen Farmacêutica São Paulo, Brazil | Biotech | Phase 3 | VIEW |
| 42. |  Aquinas Companies, LLC (Fannin Innovation Studio) Houston, Texas, USA | Biotech | Phase 2 | VIEW |
| 43. |  Aquitaine Science Transfert (SATT Aquitaine) Talence, France | CRO | Discovery | VIEW |
| 44. |  Arcera Life Sciences Abu Dhabi, United Arab Emirates | Biotech | Commercial | VIEW |
| 45. |  | CDMO | Commercial | VIEW |
| 46. |  Argo Biopharma Shanghai, China | Biotech | Phase 2 | VIEW |
| 47. |  | CRO | Commercial | VIEW |
| 48. |  Ark Biosciences Shanghai, China | Biotech | Commercial | VIEW |
| 49. |  Arrivo BioVentures Morrisville, USA | Biotech | Phase 2 | VIEW |
| 50. |  Artificial Axon Labs Cambridge, Massachusetts, USA | Biotech | Discovery | VIEW |
| 51. |  Arvinas, Inc. New Haven, Connecticut, United States | Biotech | Phase 1-3 | VIEW |
| 52. |  Assertio Holdings, Inc. Lake Forest, USA | Biotech | Commercial | VIEW |
| 53. |  AstraZeneca Cambridge, United Kingdom | Pharma | Phase 1|Phase 2|Phase 3|Pre-registration|Commercial | VIEW |
| 54. |  Aurigene Pharmaceutical Services Limited Bengaluru, India | CDMO | Commercial | VIEW |
| 55. |  Aurobindo Pharma Limited Hyderabad, India | Pharma | Commercial | VIEW |
| 56. |  AutoCruitment Atlanta, Georgia, USA | CRO | Commercial | VIEW |
| 57. |  Autobahn Therapeutics San Diego, USA | Biotech | Phase 2 | VIEW |
| 58. |  Axalbion Lausanne, Switzerland | Biotech | Phase 2 | VIEW |
| 59. |  BC Platforms Zurich, Switzerland | Digital Health | Commercial | VIEW |
| 60. |  BNPLAB Co., Ltd. Seoul, South Korea | CRO | Commercial | VIEW |
| 61. |  BSP Pharmaceuticals S.p.A. Latina, Italy | CDMO | Commercial | VIEW |
| 62. |  Bangkok Dusit Medical Services (BDMS) Bangkok, Thailand | Pharma | Commercial | VIEW |
| 63. |  Baptist Health (Alabama) Montgomery, Alabama, United States | MedTech | - | VIEW |
| 64. |  Bausch Health Laval, Canada | Pharma | Commercial | VIEW |
| 65. |  | Pharma | Discovery through Commercial | VIEW |
| 66. |  Beacon Hospital Dublin, Ireland | MedTech | - | VIEW |
| 67. |  Beijing Haibu Pharmaceutical Technology Co., Ltd. Beijing, China | CRO | Discovery | VIEW |
| 68. |  Belief BioMed Shanghai, China | Biotech | Commercial | VIEW |
| 69. |  BenevolentAI London, United Kingdom | Biotech | Phase 1|Phase 2|Preclinical | VIEW |
| 70. |  Berg Health Framingham, Massachusetts, USA | Biotech | Phase 1/2 | VIEW |
| 71. |  Binex Co., Ltd. Busan, South Korea | CDMO | Commercial | VIEW |
| 72. |  BioChain Institute Inc. Newark, California, USA | Diagnostics | Commercial | VIEW |
| 73. |  BioDuro-Sundia Irvine, USA | CRO | Commercial | VIEW |
| 74. |  Bioclinica Princeton, New Jersey, USA | CRO | Commercial | VIEW |
| 75. |  Biocon Limited Bengaluru, India | Pharma | Commercial, Phase 3, Phase 2, Phase 1 | VIEW |
| 76. |  Biohaven Ltd. New Haven, USA | Biotech | Phase 3 | VIEW |
| 77. |  Biotech Advisory Lab Basel, Switzerland | CRO | Commercial | VIEW |
| 78. |  Blanchard Valley Health System Findlay, USA | MedTech | Commercial | VIEW |
| 79. |  BlueRock Therapeutics Cambridge, USA | Biotech | Phase 3 | VIEW |
| 80. |  Boryung Seoul, South Korea | Pharma | Commercial | VIEW |
| 81. |  Bracco Imaging S.p.A. Milan, Italy | Pharma | Commercial | VIEW |
| 82. |  BrainXell, Inc. Madison, WI, USA | Biotech | Preclinical | VIEW |
| 83. |  Bristol Myers Squibb Princeton, New Jersey, United States | Pharma | Phase 1-3 and Commercial | VIEW |
| 84. |  Brookes Pharma (Pvt.) Ltd. Karachi, Pakistan | CDMO | Commercial | VIEW |
| 85. |  C&R Research Inc. Seoul, South Korea | CRO | N/A | VIEW |
| 86. |  | Digital Health | Commercial | VIEW |
| 87. |  CECOS University of Information Technology and Emerging Sciences Peshawar, Pakistan | Biotech | Preclinical | VIEW |
| 88. |  CEMKA Bourg-la-Reine, France | CRO | Commercial | VIEW |
| 89. |  CHUV (Centre Hospitalier Universitaire Vaudois) Lausanne, Switzerland | Biotech | Phase 3 | VIEW |
| 90. |  CURE5 Foundation New York, USA | Biotech | Discovery | VIEW |
| 91. |  Cabaletta Bio, Inc. Philadelphia, USA | Biotech | Phase 1/2 | VIEW |
| 92. |  Cadence Design Systems San Jose, USA | Digital Health | Commercial | VIEW |
| 93. |  Calico Life Sciences South San Francisco, United States | Biotech | Phase 2 | VIEW |
| 94. |  Cambridge Consultants Cambridge, United Kingdom | MedTech | Commercial | VIEW |
| 95. |  | Biotech | Commercial | VIEW |
| 96. |  | Digital Health | Commercial | VIEW |
| 97. |  Carbogen Amcis Bubendorf, Switzerland | CDMO | Commercial | VIEW |
| 98. |  Cardinal Health Dublin, Ohio, USA | MedTech | Commercial | VIEW |
| 99. |  Cell-Tx Seoul, South Korea | Biotech | Preclinical | VIEW |
| 100. |  Celon Pharma Łomianki, Poland | Biotech | Phase 3 | VIEW |
| 101. |  Center for Neuromusculoskeletal Restorative Medicine Limited Shatin, Hong Kong | Biotech | Preclinical | VIEW |
| 102. |  Centre for Human Drug Research Leiden, Netherlands | CRO | Discovery | VIEW |
| 103. |  Centricity Research Columbus, Georgia, USA and Toronto, Canada | CRO | Commercial | VIEW |
| 104. |  Cerebras Systems Sunnyvale, USA | Digital Health | Commercial | VIEW |
| 105. |  Ceribell, Inc. Sunnyvale, California, USA | MedTech | Commercial | VIEW |
| 106. |  Charité – Universitätsmedizin Berlin Berlin, Germany | MedTech | Discovery | VIEW |
| 107. |  Charles River Laboratories Wilmington, Massachusetts, USA | CRO | Commercial | VIEW |
| 108. |  Charles River Laboratories Wilmington, Massachusetts, USA | CRO | Commercial | VIEW |
| 109. |  Chengdu Kanghong Pharmaceutical Group Chengdu, China | Biotech | Commercial | VIEW |
| 110. |  Chiba University Chiba, Japan | Biotech | Phase 2 | VIEW |
| 111. |  Children's Minnesota Minneapolis, Minnesota, USA | MedTech | - | VIEW |
| 112. |  China Medical System Holdings Ltd. Shenzhen, China | Biotech | Commercial | VIEW |
| 113. |  China Medical University Hospital (CMUH) Taichung, Taiwan | Biotech | Phase 2 | VIEW |
| 114. |  China Resources Double-Crane Pharmaceutical Co., Ltd. Beijing, China | Pharma | Commercial | VIEW |
| 115. |  Chinese Medical Association Publishing House (CMAPH) Beijing, China | Digital Health | Commercial | VIEW |
| 116. |  Chong Kun Dang Pharmaceutical Corp. Seoul, South Korea | Pharma | Commercial | VIEW |
| 117. |  Chung-Ang University Seoul, South Korea | Biotech | Phase 3 | VIEW |
| 118. |  Cincinnati Children's Hospital Medical Center Cincinnati, USA | Biotech | Commercial | VIEW |
| 119. |  | CRO | Commercial | VIEW |
| 120. |  ClearView Healthcare Partners Newton, USA | CRO | - | VIEW |
| 121. |  Cliantha Research Ahmedabad, India | CRO | Commercial | VIEW |
| 122. |  CliniExperts Research Services New Delhi, India | CRO | Commercial | VIEW |
| 123. |  Clinical Horizons Research Inc. Leonia, New Jersey, USA | CRO | Commercial | VIEW |
| 124. |  Clinical Outcomes Solutions Chicago, USA / Folkestone, UK | CRO | - | VIEW |
| 125. |  Clinical Process Services (CPS) Dubai, United Arab Emirates | CRO | Commercial | VIEW |
| 126. |  Clinical Service Center (CSC) Suzhou, China | CRO | Commercial | VIEW |
| 127. |  Clinuvel Pharmaceuticals Melbourne, Australia | Biotech | Commercial | VIEW |
| 128. |  Compal Electronics, Inc. Taipei, Taiwan | MedTech | Phase 2 | VIEW |
| 129. |  Constructor Group Schaffhausen, Switzerland | Biotech | Preclinical | VIEW |
| 130. |  Coral Healthcare Beijing, China | Digital Health | Commercial | VIEW |
| 131. |  Corcept Therapeutics Redwood City, USA | Biotech | Commercial | VIEW |
| 132. |  Corline Biomedical AB Uppsala, Sweden | Biotech | Phase 2 | VIEW |
| 133. |  Covenant Health Knoxville, USA | Digital Health | - | VIEW |
| 134. |  Cupperson London, United Kingdom | CRO | Self-funded | VIEW |
| 135. |  Curatis Liestal, Switzerland | Biotech | Phase 3 | VIEW |
| 136. |  Curebase San Francisco, USA | Digital Health | Commercial | VIEW |
| 137. |  Curestack Tampa, Florida, USA | Digital Health | Commercial | VIEW |
| 138. |  | CRO | Service Provider | VIEW |
| 139. |  | Biotech | Phase 2 | VIEW |
| 140. |  DEEP Measures Helsinki, Finland | Digital Health | Seed | VIEW |
| 141. |  Daewon Pharmaceutical Co., Ltd. Seoul, South Korea | Pharma | Commercial | VIEW |
| 142. |  Daewoong Pharmaceutical Seoul, South Korea | Pharma | Commercial | VIEW |
| 143. |  Daicel Chiral Technologies Hyderabad, India (Regional HQ); West Chester, PA, USA (Global HQ) | CDMO | Commercial | VIEW |
| 144. |  Daito Pharmaceutical Co., Ltd. Toyama City, Japan | CDMO | Commercial | VIEW |
| 145. |  Dankook University Yongin and Cheonan, South Korea | Biotech | Phase 2 | VIEW |
| 146. |  Dartmouth College Hanover, USA | Biotech | Phase 3 | VIEW |
| 147. |  Definitive Healthcare Framingham, USA | Digital Health | Commercial | VIEW |
| 148. |  Deloitte France Puteaux (Paris La Défense), France | CRO | Commercial | VIEW |
| 149. |  Dexcel Pharma Or Akiva, Israel | Biotech | Commercial | VIEW |
| 150. |  DifGen Pharmaceuticals Miramar, USA | Biotech | Commercial | VIEW |
| 151. |  Dr. Reddy's Laboratories Ltd. Hyderabad, India | Pharma | Commercial | VIEW |
| 152. |  Drug & Biotechnology Development, LLC Clearwater, USA | CRO | Commercial | VIEW |
| 153. |  E-Flask Seongnam, South Korea | Biotech | Phase 1 | VIEW |
| 154. |  | CRO | Commercial | VIEW |
| 155. |  ELIQUENT Life Sciences Washington, DC, USA | CRO | Commercial | VIEW |
| 156. |  EMD Serono Boston Seaport District, MA, USA (200 Pier 4 Boulevard, Boston, MA) | Pharma | Phase 1, 2, 3, and Commercial | VIEW |
| 157. |  ETH Zürich Zurich, Switzerland | Biotech | Discovery | VIEW |
| 158. |  EVERSANA Chicago, Illinois, USA | CRO | Commercial | VIEW |
| 159. |  Eczacıbaşı Group Istanbul, Turkey | Pharma | Commercial | VIEW |
| 160. |  Eczacıbaşı Pharmaceutical and Industrial Investment Co. Istanbul, Turkey | Pharma | Commercial | VIEW |
| 161. |  Eisai Co., Ltd. Tokyo, Japan | Pharma | Commercial | VIEW |
| 162. |  Eisai Co., Ltd. Tokyo, Japan | Pharma | Commercial | VIEW |
| 163. |  Eisai Co., Ltd. Tokyo, Japan | Pharma | Commercial | VIEW |
| 164. |  Eisai Pharmaceuticals India Mumbai, India | Pharma | Commercial | VIEW |
| 165. |  Electronics and Telecommunications Research Institute (ETRI) Daejeon, South Korea | Digital Health | Discovery | VIEW |
| 166. |  Elevance Health Indianapolis, USA | Digital Health | Commercial | VIEW |
| 167. |  Eli Lilly and Company Indianapolis, Indiana, USA | Pharma | Phase 1-Phase 3 and Commercial | VIEW |
| 168. |  Emblem AI San Francisco, USA | Digital Health | Commercial | VIEW |
| 169. |  Encompass Communications and Learning Edgewater, USA | CRO | - | VIEW |
| 170. |  Escientia Life Sciences South Windsor, Connecticut, USA | CDMO | Commercial | VIEW |
| 171. |  Escientia Life Sciences Hyderabad, India | CDMO | Commercial | VIEW |
| 172. |  | Pharma | Commercial | VIEW |
| 173. |  Esteve Healthcare Barcelona, Spain | Pharma | Commercial | VIEW |
| 174. |  Ethypharm Saint-Cloud, France | Biotech | Commercial | VIEW |
| 175. |  Eugia US LLC East Windsor, New Jersey, USA | Biotech | Commercial | VIEW |
| 176. |  EurimPharm Arzneimittel GmbH Saaldorf-Surheim, Germany | Biotech | Commercial | VIEW |
| 177. |  Eurofins PHAST GmbH Homburg, Germany | CRO | Commercial | VIEW |
| 178. |  European Medicines BV Lelystad, Netherlands | CRO | Commercial | VIEW |
| 179. |  EvergreenHealth Kirkland, USA | Digital Health | - | VIEW |
| 180. |  Evolution Health Group, LLC Pearl River, New York, USA | CRO | Commercial | VIEW |
| 181. |  Evotec SE Hamburg, Germany | Biotech | Commercial | VIEW |
| 182. |  Exeltis Florham Park, USA (Global HQ in Madrid, Spain) | Biotech | Commercial | VIEW |
| 183. |  ExtractumPharma Budapest, Hungary | CDMO | Commercial | VIEW |
| 184. |  | CDMO | Commercial | VIEW |
| 185. |  Fakeeh Care Group Jeddah, Saudi Arabia | Digital Health | - | VIEW |
| 186. |  | Pharma | Commercial | VIEW |
| 187. |  | Pharma | Commercial | VIEW |
| 188. |  Fidelity Investments Boston, USA | Pharma | Commercial | VIEW |
| 189. |  Florence Healthcare Atlanta, USA | Digital Health | Commercial | VIEW |
| 190. |  Focus Care Pharmaceuticals B.V. Zaandam, Netherlands | Biotech | Commercial | VIEW |
| 191. |  Formation Bio New York, USA | Biotech | Phase 3 | VIEW |
| 192. |  Fortrea Durham, North Carolina, USA | CRO | Commercial | VIEW |
| 193. |  Fosun Pharma Shanghai, China | Pharma | Commercial | VIEW |
| 194. |  Freyr Solutions Princeton, New Jersey, USA | CRO | Commercial | VIEW |
| 195. |  Frontage Laboratories (Shanghai) Co., Ltd. Shanghai, China | CRO | Commercial | VIEW |
| 196. |  Frontage Laboratories, Inc. Exton, USA | CRO | Commercial | VIEW |
| 197. |  Fujifilm Diosynth Biotechnologies Morrisville, North Carolina, USA | CDMO | Commercial | VIEW |
| 198. |  | Digital Health | Commercial | VIEW |
| 199. |  G&L Scientific Marlow, United Kingdom | CRO | Commercial | VIEW |
| 200. |  G. H. Raisoni University Saikheda, India | Biotech | Discovery | VIEW |
| 201. |  GC Biopharma Corp. (formerly Green Cross Corporation) Yongin, Gyeonggi Province, South Korea | Pharma | Multiple stages (Discovery through Commercial) | VIEW |
| 202. |  GE HealthCare Chicago, USA (Global); Lindesnes/Oslo, Norway (PDx R&D/Manufacturing) | MedTech | Commercial | VIEW |
| 203. |  | Biotech | Phase 1|Phase 2|Commercial | VIEW |
| 204. |  GNT Pharma Yongin, South Korea | Biotech | Phase 3 | VIEW |
| 205. |  Gedeon Richter Budapest, Hungary | Pharma | Commercial | VIEW |
| 206. |  GenAns Biotech Beijing, China | Biotech | Preclinical | VIEW |
| 207. |  Gene Oasis Singapore, Singapore | Biotech | Clinical | VIEW |
| 208. |  GeneBiology, Inc. Research Triangle Park, North Carolina, USA | Biotech | Clinical | VIEW |
| 209. |  Genentech South San Francisco, California, United States | Biotech | Discovery through Commercial | VIEW |
| 210. |  | Digital Health | Commercial | VIEW |
| 211. |  George Mason University Fairfax, USA | Biotech | Phase 2 | VIEW |
| 212. |  Georgia Southern University Statesboro, USA | Biotech | Discovery | VIEW |
| 213. |  Giddi Pharma Co., Ltd. Taichung, Taiwan | CRO | Commercial | VIEW |
| 214. |  Giddi Pharma Co., Ltd. Taichung City, Taiwan | CRO | Commercial | VIEW |
| 215. |  Global Life Sciences Alliance Philadelphia, PA, USA | CRO | Commercial | VIEW |
| 216. |  GlobalData Plc London, United Kingdom | Digital Health | Commercial | VIEW |
| 217. |  Glukem Biocare Hyderabad, India | CDMO | Commercial | VIEW |
| 218. |  Golden State Medical Supply (GSMS) Camarillo, California, USA | CDMO | Commercial | VIEW |
| 219. |  Graematter, Inc. St. Louis, USA | Digital Health | Commercial | VIEW |
| 220. |  Grifols, S.A. Sant Cugat del Vallès (Barcelona), Spain | Pharma | Phase 3 | VIEW |
| 221. |  Guangzhou Cellprotek Pharmaceutical Guangzhou, China | Biotech | Phase 3 (Planning) | VIEW |
| 222. |  Gypto Pharma Khanka, Qalyubia, Egypt | CDMO | Commercial | VIEW |
| 223. |  H. Lundbeck A/S Valby, Copenhagen, Denmark | Pharma | Commercial | VIEW |
| 224. |  HBM Partners Zug, Switzerland | Biotech | Commercial | VIEW |
| 225. |  | CRO | Commercial | VIEW |
| 226. |  HKSH Medical Group Happy Valley, Hong Kong | CRO | Commercial | VIEW |
| 227. |  Halozyme Therapeutics San Diego, USA | Biotech | Commercial | VIEW |
| 228. |  Hansoh Pharmaceutical Group Co., Ltd. Shanghai, China | Biotech | Phase 3 | VIEW |
| 229. |  Hanyang University Seoul, South Korea | Biotech | Phase 2 | VIEW |
| 230. |  Harman Finochem Ltd. Mumbai, India | CDMO | Commercial | VIEW |
| 231. |  Harmony Biosciences Holdings, Inc. Plymouth Meeting, USA | Biotech | Commercial | VIEW |
| 232. |  Haymarket Media Group London, United Kingdom | Digital Health | Commercial | VIEW |
| 233. |  | Biotech | Phase 3 | VIEW |
| 234. |  Healis Therapeutics Cambridge, USA | Biotech | Phase 2/3 | VIEW |
| 235. |  | Pharma | Commercial | VIEW |
| 236. |  | Pharma | Commercial | VIEW |
| 237. |  Hetero Drugs Limited Hyderabad, India | Biotech | Commercial | VIEW |
| 238. |  Hetero Healthcare Ltd Hyderabad, India | Pharma | Commercial | VIEW |
| 239. |  Hevolution Foundation Riyadh, Saudi Arabia | Biotech | Discovery | VIEW |
| 240. |  Hexal AG Holzkirchen, Germany | Pharma | Commercial | VIEW |
| 241. |  Hikma Pharmaceuticals London, United Kingdom | Pharma | Commercial | VIEW |
| 242. |  | MedTech | Commercial | VIEW |
| 243. |  Hong Kong University of Science and Technology (Guangzhou) Guangzhou, China | Biotech | Phase 2 | VIEW |
| 244. |  Horizon BioInsights LLC San Francisco, USA | CRO | - | VIEW |
| 245. |  Hospital Alemão Oswaldo Cruz São Paulo, Brazil | Diagnostics | Commercial | VIEW |
| 246. |  Hospital Canselor Tuanku Muhriz UKM (HCTM) Kuala Lumpur, Malaysia | MedTech | - | VIEW |
| 247. |  Hospital Clínico Universidad de Chile (HCUCH) Santiago, Chile | MedTech | - | VIEW |
| 248. |  Hospital Israelita Albert Einstein São Paulo, Brazil | Diagnostics | Commercial | VIEW |
| 249. |  Hospital Italiano de Buenos Aires Buenos Aires, Argentina | MedTech | Discovery | VIEW |
| 250. |  Hospital Sisters Health System Springfield, Illinois, USA | MedTech | Commercial | VIEW |
| 251. |  Houston Methodist Houston, USA | Biotech | Discovery | VIEW |
| 252. |  Humanitas Research Hospital (IRCCS) Rozzano (Milan), Italy | Biotech | Discovery | VIEW |
| 253. |  Humanwell Healthcare Wuhan, China | Pharma | Commercial | VIEW |
| 254. |  HungaroTrial CRO Budapest, Hungary | CRO | Commercial | VIEW |
| 255. |  Huron Consulting Group Chicago, USA | CRO | Commercial | VIEW |
| 256. |  Hypha Discovery Ltd Abingdon, United Kingdom | CRO | Discovery | VIEW |
| 257. |  IQVIA Durham, North Carolina, United States (Primary) / Danbury, Connecticut, United States (Secondary) | CRO | N/A - Service Provider | VIEW |
| 258. |  Iasis Pharma Kamatero, Greece | Biotech | Commercial | VIEW |
| 259. |  Idorsia Allschwil, Switzerland | Biotech | Commercial | VIEW |
| 260. |  Ignis Therapeutics Shanghai, China | Biotech | Phase 3 | VIEW |
| 261. |  Imexpharm Corporation Cao Lãnh, Vietnam | Biotech | Commercial | VIEW |
| 262. |  Immunovant, Inc. Durham, North Carolina, USA | Biotech | Phase 3 | VIEW |
| 263. |  Incepta Pharmaceuticals Ltd. Dhaka, Bangladesh | Pharma | Commercial | VIEW |
| 264. |  Indegene Princeton, USA / Bangalore, India | CRO | N/A | VIEW |
| 265. |  | CRO | Commercial | VIEW |
| 266. |  Institute for Bioengineering of Catalonia (IBEC) Barcelona, Spain | Biotech | Preclinical | VIEW |
| 267. |  Institute for Medical Information Processing, Biometry and Epidemiology (IBE), LMU Munich Munich, Germany | CRO | Commercial | VIEW |
| 268. |  Insud Pharma Madrid, Spain | Biotech | Commercial | VIEW |
| 269. |  Intas Pharmaceuticals Limited Ahmedabad, India | Biotech | Commercial | VIEW |
| 270. |  Intas Pharmaceuticals Ltd. Ahmedabad, India | Pharma | Commercial | VIEW |
| 271. |  Intellia Therapeutics Cambridge, USA | Biotech | Phase 3 | VIEW |
| 272. |  Inttl Advocare New Delhi, India | CRO | Commercial | VIEW |
| 273. |  IntuitionLabs San Jose, California, USA | Digital Health | Commercial | VIEW |
| 274. |  Ionis Pharmaceuticals, Inc. Carlsbad, USA | Biotech | Commercial | VIEW |
| 275. |  Ionis Pharmaceuticals, Inc. Carlsbad, California, United States | Biotech | Phase 1 through Commercial | VIEW |
| 276. |  Ipsen Boulogne-Billancourt, France | Pharma | Commercial | VIEW |
| 277. |  | Diagnostics | Commercial | VIEW |
| 278. |  Italfarmaco Group Milan, Italy | Pharma | Commercial | VIEW |
| 279. |  J-Pharma Co., Ltd. Tokyo, Japan | Biotech | Phase 3 | VIEW |
| 280. |  JCR Pharmaceuticals Co., Ltd. Ashiya, Japan | Biotech | Phase 3 | VIEW |
| 281. |  JOINN Laboratories Beijing, China | CRO | Commercial | VIEW |
| 282. |  Jaba Recordati Porto Salvo, Portugal | Pharma | Commercial | VIEW |
| 283. |  Jamp Pharma Group Boucherville, Canada | Pharma | Commercial | VIEW |
| 284. |  Jazz Pharmaceuticals Dublin, Ireland | Pharma | Phase 1 through Commercial | VIEW |
| 285. |  Jiangsu Changyida Medical Technology Co., Ltd. (Neulive) Nantong, China | MedTech | Commercial/Clinical | VIEW |
| 286. |  Johnson & Johnson New Brunswick, New Jersey, USA | Pharma | Commercial | VIEW |
| 287. |  Jubilant Biosys Limited Noida, India | CRO | Discovery | VIEW |
| 288. |  Jubilant Pharmova Limited Noida, India | Pharma | Phase 2 | VIEW |
| 289. |  KMK Consulting Inc. Morristown, New Jersey, USA | CRO | Commercial | VIEW |
| 290. |  Karolinska Institutet Stockholm, Sweden | Biotech | Discovery | VIEW |
| 291. |  Keenova Therapeutics (formerly Endo Pharmaceuticals/Mallinckrodt Specialty Brands) Dublin, Ireland | Pharma | Commercial|Phase 1-3 | VIEW |
| 292. |  Kenai Therapeutics San Diego, USA | Biotech | Phase 1 | VIEW |
| 293. |  Kern Pharma Terrassa, Spain | CDMO | Commercial | VIEW |
| 294. |  Kindstar Global Wuhan, China | Diagnostics | Commercial | VIEW |
| 295. |  Kinexum Harpers Ferry, USA | CRO | Commercial | VIEW |
| 296. |  King Faisal Specialist Hospital and Research Centre (KFSHRC) Riyadh, Saudi Arabia | Biotech | Clinical | VIEW |
| 297. |  Kitasato University Tokyo, Japan | Biotech | Discovery | VIEW |
| 298. |  Knight Therapeutics Inc. Montreal, Canada | Biotech | Commercial | VIEW |
| 299. |  Komtur Pharmaceuticals Freiburg, Germany | CRO | Commercial | VIEW |
| 300. |  Kopran Limited Mumbai, India | CDMO | Commercial | VIEW |
| 301. |  Kubost Research Georgia, United States | CRO | - | VIEW |
| 302. |  Kusum Healthcare Pvt Ltd New Delhi, India | Pharma | - | VIEW |
| 303. |  | Pharma | Commercial | VIEW |
| 304. |  Kyung Hee University Seoul, South Korea | Biotech | Phase 3 | VIEW |
| 305. |  LGM Pharma Boca Raton, USA | CDMO | Commercial | VIEW |
| 306. |  Labcorp Burlington, North Carolina, USA | Diagnostics | Commercial | VIEW |
| 307. |  Laboratoire Aguettant Lyon, France | Biotech | Commercial | VIEW |
| 308. |  Laboratoires Servier Orléans, France | Pharma | Preclinical through Commercial | VIEW |
| 309. |  Laboratorios Bagó Buenos Aires, Argentina | Biotech | Commercial | VIEW |
| 310. |  Laboratorios Best Mexico City, Mexico | CDMO | Commercial | VIEW |
| 311. |  Laboratorios Senosiain Mexico City, Mexico | Pharma | Commercial | VIEW |
| 312. |  Laboratorios Silanes Mexico City, Mexico | Biotech | Commercial | VIEW |
| 313. |  Lantheus Holdings, Inc. Bedford, Massachusetts, USA | Biotech | Commercial | VIEW |
| 314. |  Lavipharm SA Paiania, Greece | CDMO | Commercial | VIEW |
| 315. |  Lekli Pharma (LEKLI sh.p.k.) Tirana, Albania | Biotech | Commercial | VIEW |
| 316. |  Leoben Research Rome, Italy | CRO | Commercial | VIEW |
| 317. |  Libbs Farmacêutica São Paulo, Brazil | Pharma | Commercial | VIEW |
| 318. |  Life Science Strategy Group Menlo Park, USA | CRO | Commercial | VIEW |
| 319. |  Link Innovations Bengaluru, India | Digital Health | Commercial | VIEW |
| 320. |  | CDMO | Commercial | VIEW |
| 321. |  Lotus Pharmaceutical Co., Ltd. Taipei, Taiwan | Biotech | Commercial | VIEW |
| 322. |  Luye Pharma Group Hong Kong, China | Pharma | Commercial | VIEW |
| 323. |  MARS Group Inc. Bloomington, Illinois, USA | CRO | Commercial | VIEW |
| 324. |  MEPSGEN Seoul, South Korea | Biotech | Preclinical | VIEW |
| 325. |  MERIT CRO, Inc. Madison, USA | CRO | - | VIEW |
| 326. |  MITRO Biotech Co., Ltd. Nanjing, China | CRO | Commercial | VIEW |
| 327. |  | Biotech | Commercial | VIEW |
| 328. |  MSD Rahway, New Jersey, USA | Pharma | Commercial | VIEW |
| 329. |  MSN Laboratories Hyderabad, India | Pharma | Commercial | VIEW |
| 330. |  Malaysian Pharmaceutical Industries Sdn. Bhd. Bayan Lepas, Malaysia | Biotech | Commercial | VIEW |
| 331. |  Matrix Pharma Corp Private Limited Hyderabad, India | CDMO | Commercial | VIEW |
| 332. |  Maxis Clinical Sciences Edison, United States | CRO | Unfunded | VIEW |
| 333. |  McLaren Health Care Grand Blanc, United States | Digital Health | - | VIEW |
| 334. |  Meclinas Mechelen, Belgium | CRO | Commercial | VIEW |
| 335. |  Med Tech Epi, LLC Philadelphia, USA | CRO | - | VIEW |
| 336. |  MedAssessment, Inc. San Clemente, USA | CRO | Commercial | VIEW |
| 337. |  | CRO | Commercial | VIEW |
| 338. |  Medical University of Silesia Katowice, Poland | Diagnostics | Commercial | VIEW |
| 339. |  Medison Pharma Petah Tikva, Israel | Biotech | Commercial | VIEW |
| 340. |  Meditop Pharmaceutical Ltd. Pilisborosjenő, Hungary | CDMO | Commercial | VIEW |
| 341. |  Medreich Limited Bengaluru, India | CDMO | Commercial | VIEW |
| 342. |  | MedTech | Commercial | VIEW |
| 343. |  Mega Lifesciences Bangkok, Thailand | Pharma | Commercial | VIEW |
| 344. |  Meiji Seika Pharma Tokyo, Japan | Pharma | Phase 3 | VIEW |
| 345. |  Mentor Technical Group Caguas, Puerto Rico | CRO | Commercial | VIEW |
| 346. |  Merck & Co., Inc. Rahway, New Jersey, United States | Pharma | Phase 1-Phase 3 and Commercial | VIEW |
| 347. |  Merck KGaA Darmstadt, Germany | Pharma | Phase 3 | VIEW |
| 348. |  Merck KGaA, Darmstadt, Germany Darmstadt, Germany | Pharma | Commercial | VIEW |
| 349. |  Merck KGaA, Darmstadt, Germany Darmstadt, Germany | Pharma | Commercial | VIEW |
| 350. |  Merz Pharma GmbH & Co. KGaA Frankfurt am Main, Germany | Biotech | Phase 3 | VIEW |
| 351. |  Mesa Green Pharma Frederick, USA | Biotech | Preclinical | VIEW |
| 352. |  MetaQ Trials Tel Aviv, Israel | Digital Health | Commercial | VIEW |
| 353. |  MicroTransponder Austin, Texas, USA | MedTech | Commercial | VIEW |
| 354. |  Micron, Inc. Minato-ku, Tokyo, Japan (with Kobe operations history) | CRO | Clinical Development Support | VIEW |
| 355. |  MilliporeSigma Burlington, USA / Darmstadt, Germany | CDMO | Commercial | VIEW |
| 356. |  MiraxBioPharma (MB Pharma) Khimki, Russia | Biotech | Commercial | VIEW |
| 357. |  NAMSA Northwood, Ohio, USA | CRO | Commercial | VIEW |
| 358. |  | CRO | Commercial | VIEW |
| 359. |  NORC at the University of Chicago Chicago, USA | CRO | - | VIEW |
| 360. |  | CRO | Discovery | VIEW |
| 361. |  Nagase & Co., Ltd. Tokyo, Japan | Pharma | Commercial | VIEW |
| 362. |  Nantong University Nantong, China | Biotech | Phase 3 | VIEW |
| 363. |  Natco Pharma Limited Hyderabad, India | Biotech | Commercial | VIEW |
| 364. |  National Hospital Organization (NHO) Tokyo, Japan | MedTech | Discovery | VIEW |
| 365. |  National Research University Higher School of Economics Moscow, Russia | Digital Health | Discovery | VIEW |
| 366. |  Nebraska Medicine Omaha, USA | Digital Health | - | VIEW |
| 367. |  Neuland Laboratories Limited Hyderabad, India | CDMO | Commercial | VIEW |
| 368. |  NeuroCare Health P.C. Greenwich, USA | Digital Health | Discovery | VIEW |
| 369. |  Neurocrine Biosciences San Diego, USA | Biotech | Commercial | VIEW |
| 370. |  Neurogene Inc. New York, NY | Biotech | Phase 2 | VIEW |
| 371. |  Neutec Pharmaceutical Istanbul, Turkey | Pharma | Commercial | VIEW |
| 372. |  NewYork-Presbyterian Hospital New York, USA | Digital Health | - | VIEW |
| 373. |  Nicklaus Children's Health System Miami, USA | MedTech | Commercial | VIEW |
| 374. |  Nicolab Amsterdam, Netherlands | Digital Health | Commercial | VIEW |
| 375. |  Nihon Medi-Physics Co., Ltd. (NMP) Tokyo, Japan | Biotech | Commercial | VIEW |
| 376. |  Nipro Corporation Osaka, Japan | MedTech | Commercial | VIEW |
| 377. |  North Mississippi Health Services Tupelo, USA | MedTech | - | VIEW |
| 378. |  Notrox Research Bangalore, India | CRO | Commercial | VIEW |
| 379. |  Novartis Basel, Switzerland | Pharma | Phase 2, Phase 3, Commercial | VIEW |
| 380. |  Noveome Biotherapeutics Pittsburgh, Pennsylvania, USA | Biotech | Phase 1-2 | VIEW |
| 381. |  | CRO | Discovery through Phase IV | VIEW |
| 382. |  Null Hypothesis Hangzhou, China | Digital Health | Commercial | VIEW |
| 383. |  ONO PHARMA UK LTD London, United Kingdom | Pharma | Phase 1 through Commercial | VIEW |
| 384. |  ONO Pharmaceutical Osaka, Japan (Chuo-ku) | Pharma | Phase 1-Phase 3 | VIEW |
| 385. |  Oban BioPharma Stamford, USA | Biotech | Preclinical | VIEW |
| 386. |  Olpha (JSC Olpha) Olaine, Latvia | Biotech | Commercial | VIEW |
| 387. |  Optum Eden Prairie, Minnesota, USA | Digital Health | Commercial | VIEW |
| 388. |  OrBion Pharmaceuticals Private Limited Chennai, India | Biotech | Commercial | VIEW |
| 389. |  Orlando Health Orlando, USA | Digital Health | - | VIEW |
| 390. |  Otsuka Pharmaceutical Co., Ltd. Tokyo, Japan | Pharma | Commercial | VIEW |
| 391. |  | CRO | - | VIEW |
| 392. |  PBS Regulatory Consulting Bridgewater, New Jersey, USA | CRO | Commercial | VIEW |
| 393. |  | Pharma | Commercial | VIEW |
| 394. |  PPD (Pharmaceutical Product Development) Wilmington, North Carolina, USA | CRO | Commercial | VIEW |
| 395. |  | CRO | Commercial | VIEW |
| 396. |  PT Meprofarm Bandung, Indonesia | Pharma | Commercial | VIEW |
| 397. |  PYC Therapeutics Nedlands, Australia | Biotech | Clinical | VIEW |
| 398. |  Par Health St. Louis, Missouri, United States | Pharma | Commercial (focus on generic development and manufacturing) | VIEW |
| 399. |  Parexel Raleigh, North Carolina, USA | CRO | Phase I-IV (as a CRO, Parexel manages client pipelines, not its own) | VIEW |
| 400. |  Partex NV Eschborn, Germany | Biotech | Phase 2 | VIEW |
| 401. |  Pasithea Therapeutics Corp. Miami Beach, USA | Biotech | Phase 1 | VIEW |
| 402. |  Pfizer New York, United States | Pharma | Phase 1-3 and pending approval | VIEW |
| 403. |  Pharma Clinical Ness Ziona, Israel | CRO | - | VIEW |
| 404. |  PharmaBlock Sciences (Nanjing), Inc. Nanjing, China | CDMO | Commercial | VIEW |
| 405. |  PharmaLex Mannheim, Germany (Hans-Thoma-Straße 22, 68163 Mannheim) / Bad Homburg, Germany | CRO | N/A - Service Provider (not drug developer) | VIEW |
| 406. |  PharmaLex (now Cencora PharmaLex) Multiple global headquarters; main offices in Switzerland and US | CRO | Consulting/Support across all stages - Discovery through Phase 4 | VIEW |
| 407. |  | CRO | Commercial | VIEW |
| 408. |  | CRO | N/A | VIEW |
| 409. |  Pharmascience Inc. Montreal, Canada | Pharma | Commercial | VIEW |
| 410. |  PicnicHealth San Francisco, USA | Digital Health | Commercial | VIEW |
| 411. |  Piramal Pharma Limited Mumbai, India | CDMO | Commercial Manufacturing (primarily services other companies' pipelines) | VIEW |
| 412. |  PlasmaGen BioSciences Bengaluru (Chamrajpet), India | Biotech | Commercial/Manufacturing | VIEW |
| 413. |  Plus Therapeutics, Inc. Houston, Texas, USA | Biotech | Phase 2 | VIEW |
| 414. |  Policlinico Gemelli Rome, Italy | CRO | Commercial | VIEW |
| 415. |  Precision Medicine Group Bethesda, USA | CRO | Commercial | VIEW |
| 416. |  Precision for Medicine Bethesda, Maryland, USA | CRO | Commercial | VIEW |
| 417. |  Premier Research Morrisville, North Carolina, USA | CRO | N/A (Service Provider) | VIEW |
| 418. |  | Digital Health | - | VIEW |
| 419. |  Qilu Pharmaceutical 8888 Lvyou Road, High-tech Zone, Jinan, China | Pharma | Discovery through Commercial | VIEW |
| 420. |  Qingdao Huapushi Technology Co., Ltd. Qingdao, China | Digital Health | Commercial | VIEW |
| 421. |  Quanterix Corporation Billerica, Massachusetts, USA | Diagnostics | Commercial | VIEW |
| 422. |  Queensland Health Brisbane, Australia | Digital Health | Commercial | VIEW |
| 423. |  RAFARM S.A. Paiania, Greece | CDMO | Commercial | VIEW |
| 424. |  RCSI University of Medicine and Health Sciences Dublin, Ireland | Biotech | Discovery | VIEW |
| 425. |  RQM+ Monroeville, Pennsylvania, USA | CRO | Commercial | VIEW |
| 426. |  RWS Group Chalfont St Peter, United Kingdom | CRO | Commercial | VIEW |
| 427. |  Radiant Pharmaceuticals Limited Dhaka, Bangladesh | Pharma | Commercial | VIEW |
| 428. |  Rancho BioSciences San Diego, USA | CRO | - | VIEW |
| 429. |  Recursion Pharmaceuticals Salt Lake City, Utah, USA | Biotech | Phase 1-2 | VIEW |
| 430. |  Redbird Research Las Vegas, USA | CRO | Commercial | VIEW |
| 431. |  Renata PLC Dhaka, Bangladesh | Pharma | Commercial | VIEW |
| 432. |  Rho Durham, North Carolina, USA | CRO | Commercial | VIEW |
| 433. |  | CRO | Commercial | VIEW |
| 434. |  | Pharma | Discovery|Preclinical|Phase 1|Phase 2|Phase 3|Commercial | VIEW |
| 435. |  | Pharma | Commercial | VIEW |
| 436. |  Roche Holding AG (via businesspartner.roche.com portal) Basel, Switzerland | Pharma | Phase 1 through Commercial | VIEW |
| 437. |  Rosmi Biotech Hyderabad, India | CDMO | Commercial | VIEW |
| 438. |  Rugen Therapeutics (Rugen Biomed) Boston, USA / Suzhou, China | Biotech | Preclinical | VIEW |
| 439. |  SAIFU Laboratories (Beijing Saifu Pharmaceutical Research Institute Co., Ltd.) Beijing, China | CRO | Discovery | VIEW |
| 440. |  SCOPE International AG Mannheim, Germany | CRO | N/A | VIEW |
| 441. |  SPIMACO Riyadh, Saudi Arabia | Biotech | Commercial | VIEW |
| 442. |  STADA Arzneimittel AG Bad Vilbel, Germany | Pharma | Commercial | VIEW |
| 443. |  STADA Arzneimittel AG Bad Vilbel, Germany | Pharma | Commercial | VIEW |
| 444. |  SV ChemBioTech Inc. Edmonton, Canada | CRO | Preclinical | VIEW |
| 445. |  SYFM Co., Ltd. Seoul, South Korea | CDMO | Commercial | VIEW |
| 446. |  Saama Technologies Campbell, USA | Digital Health | Commercial | VIEW |
| 447. |  Sai Life Sciences Hyderabad, India | CDMO | Commercial | VIEW |
| 448. |  Saint Novel Biotech Limited Hong Kong, China | Biotech | Discovery | VIEW |
| 449. |  | Pharma | Commercial | VIEW |
| 450. |  Sandoz Group AG Basel, Switzerland | Pharma | Commercial | VIEW |
| 451. |  | Biotech | Clinical | VIEW |
| 452. |  | Pharma | Preclinical through Phase 3 | VIEW |
| 453. |  Saol Therapeutics Roswell, USA | Biotech | Phase 3 | VIEW |
| 454. |  Sarepta Therapeutics Cambridge, USA | Biotech | Commercial | VIEW |
| 455. |  Sartorius Göttingen, Germany | CDMO | Commercial | VIEW |
| 456. |  Schulthess Klinik Zürich, Switzerland | MedTech | - | VIEW |
| 457. |  ScinoPharm Taiwan Ltd. Tainan, Taiwan | CDMO | Commercial | VIEW |
| 458. |  Selvita S.A. Krakow, Poland | CRO | Discovery | VIEW |
| 459. |  | Digital Health | Commercial | VIEW |
| 460. |  Shanghai Pharmaceuticals Holding Co., Ltd. Shanghai, China | Pharma | Phase 3 | VIEW |
| 461. |  Shionogi & Co., Ltd. Osaka, Japan | Pharma | Commercial | VIEW |
| 462. |  Shionogi B.V. (Shionogi Europe) Amsterdam, Netherlands | Pharma | Commercial | VIEW |
| 463. |  Siegfried Holding AG Zofingen, Switzerland | CDMO | Commercial | VIEW |
| 464. |  Siemens Healthineers Erlangen, Germany | MedTech | Commercial | VIEW |
| 465. |  | Pharma | Commercial | VIEW |
| 466. |  Sinotherapeutics Inc. Shanghai, China | Biotech | Commercial | VIEW |
| 467. |  Solaris Research Institute Melbourne, Australia | CRO | Commercial | VIEW |
| 468. |  Sopan Pharmaceuticals Limited Lalitpur, Nepal | Pharma | Commercial | VIEW |
| 469. |  Sopharma AD Sofia, Bulgaria | Pharma | Commercial | VIEW |
| 470. |  | Pharma | Commercial | VIEW |
| 471. |  Spark Biopharma Seoul, South Korea | Biotech | Preclinical | VIEW |
| 472. |  Spero Inc. Seoul, South Korea | CRO | Commercial | VIEW |
| 473. |  Square Pharmaceuticals PLC Dhaka, Bangladesh | Pharma | Commercial | VIEW |
| 474. |  St. David's HealthCare Austin, Texas, USA | MedTech | - | VIEW |
| 475. |  St. Luke's Health System Boise, USA | Digital Health | - | VIEW |
| 476. |  Stoke Therapeutics Bedford, USA (Moving to Waltham, MA in late 2026) | Biotech | Phase 3 | VIEW |
| 477. |  Strides Pharma Science Limited Bengaluru, India | Biotech | Commercial | VIEW |
| 478. |  Sun Pharmaceutical Industries Ltd. Mumbai, India | Pharma | Commercial | VIEW |
| 479. |  Supernus Pharmaceuticals, Inc. Rockville, MD, USA | Biotech | Commercial | VIEW |
| 480. |  Swiss Garnier Life Sciences Chennai, India | CDMO | Commercial | VIEW |
| 481. |  Switch Therapeutics South San Francisco, USA | Biotech | Preclinical | VIEW |
| 482. |  Syneos Health Morrisville, North Carolina, USA | CRO | Not applicable - Syneos Health supports client pipelines across all stages (Discovery to Commercial) | VIEW |
| 483. |  Syngene International Bengaluru, India | CRO | Commercial | VIEW |
| 484. |  Syntegon Waiblingen, Germany | MedTech | Commercial | VIEW |
| 485. |  TCG Lifesciences Pvt Ltd Kolkata, India | CRO | Discovery | VIEW |
| 486. |  TFS HealthScience Lund, Sweden | CRO | Commercial | VIEW |
| 487. |  TRB Pharma Campinas, Brazil | Biotech | Commercial | VIEW |
| 488. |  TRG Ventures Hellerup, Denmark | Biotech | Phase 3 | VIEW |
| 489. |  Taho Pharmaceuticals Ltd. Taipei, Taiwan | Biotech | Phase 3 | VIEW |
| 490. |  Taiho Pharmaceutical Co., Ltd. Tokyo, Japan | Biotech | Commercial | VIEW |
| 491. |  Taipei Veterans General Hospital Taipei, Taiwan | MedTech | Discovery | VIEW |
| 492. |  Takeda Pharmaceutical Company Tokyo, Japan | Pharma | Phase 3 | VIEW |
| 493. |  Tamkang University New Taipei City, Taiwan | Biotech | Discovery | VIEW |
| 494. |  Tanabe Pharma Corporation Osaka, Japan | Pharma | Commercial | VIEW |
| 495. |  Tata Consultancy Services Mumbai, India | CRO | Commercial | VIEW |
| 496. |  Tech Observer Paramus, New Jersey 07652, United States | CRO | Phase 1-Phase 4 support | VIEW |
| 497. |  Technology Resources, Inc. West Chester, Pennsylvania, USA | CRO | Commercial | VIEW |
| 498. |  Ten30 Bio Alameda, CA, United States | Biotech | Discovery | VIEW |
| 499. |  Teva Pharmaceutical Industries Ltd. Tel Aviv, Israel | Pharma | Commercial | VIEW |